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INTRODUCTION
The skin is a relatively inhospitable environment for
the growth of  most pathogenic microorganisms. The
hostility of the skin environment is attributed to relative
dryness of cutaneous surfaces that provides insufficient
amount of moisture that could support significant
growth of pathogens and colonization with resident
microflora that produces metabolites that are inhibitory
to the growth of invading/competing pathogens1.
Eradication of resident flora greatly enhances the
survival of Staphylococcus aureus and the subsequent
development of infection.
Skin infections may be either primary or secondary.
Primary infections have characteristic morphologies and
courses, and are initiated by single organisms, and
usually occur in normal skin. They are most frequently
caused by Staphylococcus aureus, Streptococcus pyogenes, and
coryneform bacteria. Impetigo, folliculitis, boils, and
erythrismal are common examples. Secondary
infections originate in diseased skin as a superimposed
condition, when   the skin is damaged by inflammation,
burn or exfoliation, absorption is further increased2.
Pseudomonas aeruginosa is an opportunistic pathogen that
can cause skin infection especially in burns and wounds,
sores and ulcers often as secondary invaders. Skin
lesions have been reported to accompany Pseudomonas
aeruginosa sepsis in 13-39 percent of patients studied
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ABSTRACT
Background: Antimicrobial ointments are topical products used for the treatment of
common skin infections. Potency superiority between certain ointments and creams used
in the treatment of skin infections has been a controversial subject among clinicians.
Objective: This study was carried out to investigate the activities of some antimicrobial
ointments on selected bacteria and fungi of clinical importance that caused skin infections.
Methods: Three brands of antibacterial; gentamicin, chloramphenicol, bactroban and
two brands of antifungal ointments; nystatin and Whitefield’s were evaluated by agar -
cup diffusion method for their antimicrobial activity. Minimum inhibitory concentration,
minimum bactericidal concentration and minimum fungicidal concentration of the
ointments were determined. Kinetic study of  bactroban on all the clinical isolates was
evaluated to determine their efficacy within a specific time lag.
Results: All the isolates of Pseudomonas aeruginosa were susceptible to bactroban while
4 of the 5 isolates of Streptococcus pyogenes were resistant. Three of the five isolates of
Staphylococcus aureus were susceptible to bactroban. Gentamicin had no activity on
Pseudomonas aeruginosa while 4 of the 5 isolates of Streptococcus pyogenes were
susceptible to gentamicin. Three of the 5 isolates ofStaphylococcus aureus were susceptible
to gentamicin and varied resistance were recorded for chloramphenicol and antifungal
agents. The MIC’’s values recorded for the antimicrobial ointments examined varied
with respect to concentrations and composition. Bactroban and gentamicin gave the
MIC’s 20g/mL - 2000g/mL and 50g/mL - 400g/mL while the MIC’s range 160g/
mL - 400g/mL, 100g/mL -160g/mL and 180g/mL -200g/mL were also recoded  for
chloramphenicol, nystatin and Whitefield’s against the isolates concerned  respectively.
The MBC’s and MFC’s values recorded against the isolates doubled the values obtained
from the MIC’s.  Kinetic studies showed various population reduction to zero at varied
contact time for clinical isolates of bacterial and fungi exposed to bactroban.
Conclusion: These findings elicited potency differences among the ointments tested on
the selected clinical microbial isolates examined, this could be useful in the selection of
antimicrobial ointments for the management of skin infections caused by the
microorganisms tested and their closely related strains.
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over the years3. The dermatological manifestations of
Pseudomonas aeruginosa include erythema gangrenosum which
was however reported in 25% of patients with
bacteraemia. Staphylococcus aureus is responsible for
variety of infection syndromes that may produce local
or diffuse skin lessions by producing toxins
(Staphylococcal scalded skin syndrome and toxic shock
syndrome due to vascular invasion often in association
with carditis4. Other spectrum skin mediated infections
that Staphylococcus aureus can cause include; impetigo,
folliculitis, furuncles, and ecthyma. Fungi and yeasts
are capable of  causing many different forms of  skin
infections broadly referred to as dermatomycoses.
Dermatomycoses are a group of  common infections
generally caused by Trichophyton species. These infections
include tinea capitis, tinea barbae, tinea corporis, tinea
pedis and tinea cruris 5,6.
Candida albicans that causes vaginitis is manifested by
vaginal itching and discharge, often accompanied by
dysuria and pain. Pelvic examination may reveal a
creamy to cheesy whitish discharge, redness of the
vagina wall and external genitalia may also be present7
Antibiotic ointments are topical preparation that are
used for the treatment of  common skin infections.
They contain a medicament dissolved, suspended or
emulsified in a base and in their pharmaceutical dosage
forms, they are anti-infective and protective on host
skin8. Antimicrobial ointments are used topically for
several purposes; as protectants, antiseptics, emollients,
antipruritis, keratolytics and astringents. The use of
ointments can be an effective part of wound care,
along with regularly cleansing the wound in ensuring
speedy healing. Ointments are made up of  bases which
may be hydrocarbon (oleaginous), absorption, water
removable and water soluble type9. In general,
ointments are intended to speed healing and prevent
infection.
Some people also choose to use antibiotic ointment
on a new tattoo, though some tattoo artists advise
against this for various reasons. Antimicrobial
ointments are designed to wipe off bacterial, fungal
and yeast skin infection depending on their
formulations.  The entry of  these ointments and creams
into the skin is determined by the rate of  diffusion of
drug  from the vehicle to  the surface  of the skin,  the
partitioning of the drug from the vehicle and the
stratum, the degree of hydration of the stratum and
variation in the extent to which they increase the
hydration  of the stratum10,11.
Bactroban (mupirocin) is an antibiotic that prevents
bacteria from growing on skin when applied topically.
It is effective against impetigo and other spectrum of
Staphylococcal infection of the skin. Bactroban exerts
its bacteriostatic effect at low concentration and its
bactericidal effect at high concentration when applied
locally, it is very active against Gram negative bacteria.
Nystatin Ointment USP is virtually non-toxic and non-
sensitizing, and is well tolerated by all age groups
including debilitated infants, even on prolonged
administration. Nystatin Ointment USP is indicated in
the treatment of cutaneous or mucocutaneous   mycotic
infections caused by Candida albicans [Monilia] and other
Candida spp. The use of  certain topical ointments has
also been suggested in the treatment of  superficial
fungal infections. Nystatin Ointment USP is
contraindicated in patients with a history of
hypersensitivity to any of  its components.
Topical antimicrobial agents can be used for some
infections, but systemic therapy may be necessary for
patients with extensive disease12.
Chloramphenicol ointment is an antibiotic formulation
that is used to treat bacterial eye infections of the eyelid,
pink eye infection, bacterial inflammation of the cornea
and covering of eye. It works by stopping the growth
of bacteria13. Gentamicin ointment is used to treat
minor skin infection and infection related some skin
condition such as impetigo, folliculitis, eczema, psoriasis
and minor cuts/burns or wounds. It is an amino-
glycoside and has no effect on fungi14 . This study was
carried out therefore to determine the activity of  some
antimicrobial ointments on selected bacterial and fungal




The clinical isolates used for this findings was collected
from dermatological unit of  the Olabisi Onabanjo
University Teaching Hospital and were confirmed by
conventional biochemical characterization tests. The
organisms collected were; Pseudomonas aeruginosa,
Streptococcus pyogene, Staphylococcus aureus, typed strains
of Staphylococcus aureus ATCC29213 and Candida
albicans.
Antimicrobial ointments
The antimicrobial ointments used were:  Bactroban
(Beecham pharmaceuticals), Gentamicin ointment
(Drugfield, Nigeria) Chloramphenicol ophthalmic
ointment (Hamburg Germany), Nystatin ointment
(Squibb/USA) and Whitefield’s ointment (Nigeria).
Antimicrobial assay
The antimicrobial activity of the ointments was carried
out using the agar diffusion technique. The molten
Mueller Hinton agar medium was seeded with 0.2ml
of 1:100 overnight culture of each bacteria isolates
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while fungi isolates were surface spread with the same
dilution of  isolates respectively. Using a sterile cork
borer, 8mm wells were bored into the agar medium.
Then varied concentrations of ointments was
introduced to the wells and plates were allowed to
stand on the bench for 1 hour for pre-diffusion before
incubation at 250C and 370C for 72 hours and 24 hours
for Candida albicans and bacteria respectively. The
inhibitory zones (mm) were taken as a measure of
antimicrobial activity and interpreted according to CLSI
standard.
Determination of  Minimum Inhibitory
Concentration
Broth dilution method
A volume of 0.1mL from 10-2 dilution of an overnight
broth culture equivalent to 106 cell/mL of each of
the test organisms was pipetted into DMSO which
was  prepared in 1% concentration using Triptone soya
broth as diluent containing the respective antimicrobial
ointments prepared in the 1% DMSO in concentrations
ranging from 1000µg/mL to 25µg/mL. The tubes
were incubated at 370C for 48 hours and 25oC for 72
hours for the bacterial and Candida albicans isolates
respectively. The least concentration of  each ointment
that showed no growth was recorded as MIC and
MFC of  such ointment against the test organisms.
Determination of  Minimum Bactericidal
Concentration by Spread Plate Technique
A volume of 0.2mL of samples were removed from
the tubes used in the determination of  MIC with no
discernible growth and was spread plated on the
surface of dry nutrient agar (bacteria) medium and
Saboraud Dextrose Agar (Candida albicans) plates.
The culture plates were incubated at 370 C for 48 hrs.
and 280C for 72 hrs. for bacteria and Candida albicans
respectively. The lowest concentration of  the aliquot
which showed no trace of growth on recovery plates
was taken as the minimum bactericidal concentration.
Kinetics of Bactericidal Activity
A volume of 0.1mL of broth culture of each of every
test organism was added to a test tube containing 9.9ml
of 0.1%w/v peptone water to produce a bacterial
and fungal suspension of 106 cells per mL. Appropriate
concentration of the selected ointment: bactroban only
that was equivalent to the ½ MIC, MBC and 2MBC,
1/2 MFC,MFC and 2MFC of the ointment was added
to the suspension of  the test organism respectively. A
volume of 0.1mL of each of the suspensions was
seeded into nutrient agar medium and poured
aseptically at intervals of  0, 0.5, 1, 2,3, 4, 5, 6 and 8
hours and thereafter incubated at 370C for 48 hours
and 250C for 72 hours for bacterial and fungal
respectively. The numbers of  surviving cells per mL
were calculated and the kinetics of bactericidal activity
of  the cream was determined by plotting the
percentage survivors against time.
RESULTS
The three antibacterial ointments (bactroban, gentamicin
and chloramphenicol) and two antifungal ointments
(nystatin and Whitefield’s) were assessed for
antimicrobial activity in this study and they showed
varied antimicrobial activity on the selected test
organism. Bactroban showed antipseudomonas
activity against all the test isolates of Pseudomonas
aeruginosa were susceptible to bactroban while four out
ORGANISMS BACT GENT CHLO NYST WF
Pseudomonas aeruginosa 1 20(S) 14(R) 14(R) ND ND
Pseudomonas aeruginosa 2 25(S) 12(R) 12(R) ND ND
Pseudomonas aeruginosa 3 25(S) 12(R) 12(R) ND ND
Pseudomonas aeruginosa 4 25(S) 14(R) 12(R) ND ND
Pseudomonas aeruginosa 5 25(S) 14(R) 12(R) ND ND
Streptococcus pyogene 1 12(R) 12(S) 28(S) ND ND
Streptococcus pyogene2 14(R) 25(S) 24(S) ND ND
Streptococcus pyogene3 14(R) 32(S) 24(S) ND ND
Streptococcus pyogene4 22(S) 12(R) 12(R) ND ND
Streptococcus pyogene5 14(R) 20(S) 22(S) ND ND
Staphylococcus aureus 1 25(S) 12(R) 14(R) ND ND
Staphylococcus aureus 2 18(S) 14(R) 12(R) ND ND
Staphylococcus aureus 3 14(R) 27(S) 24(S) ND ND
Staphylococcus aureus 4 14(R) 20(S) 25(S) ND ND
Staphylococcus aureus 5 25(S) 24(S) 26(S) ND ND
Staph. aureus ATCC29213 28(S) 24(S) 12(R) ND ND
Candida albicans 1 ND ND ND 28(S) 14(R)
Candida albicans 2 ND ND ND 28(S) 25(S)
Candida albicans 3 ND ND ND 32(S) 25(S)
Candida albicans 4 ND ND ND 28(S) 30(S)
Candida albicans 5 ND ND ND 25(S) 32(S)
Table 1: Sensitivity of  selected test organisms to antimicrobial ointments.
Key:  Sensitive: +,  Resistant: -,  ND = Not Determined due to the nature of  organisms concerned.
Bact: Bactroban, Gent: Gentamicin,  Chlo: Chloramphenicol, Nyst: Nystatin, WF:Whitefield
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of the five isolates of Streptococcus pyogenes 5 were
resistant with the exception of Streptococcus pyogenes 5.
Three of the five isolates of Staphylococcus aureus and a
typed strain of Staphylococcus aureus were susceptible to
bactroban. Gentamicin, an aminoglycoside had no
activity on Pseudomonas aeruginosa but four of the five
isolates of Streptococcus pyogenes were susceptible with
the exception of Streptococcus pyogene 4 that is resistant
to gentamicin. Also, only three of  the five Staphylococcus
aureus strains were susceptible to gentamicin ointments
ointment. All the isolates of Candida albicans were
susceptible to nystatin and Whitefield’s as shown in
Table 1.
The MIC’s values of  bactroban against Pseudomonas
aeruginosa ranged from 100µg/ml -160µg/ml were
more significant than the MIC’s values of  the same
organism on gentamicin and chloramphenicol that
ranged between 200µg/ml - 400µg/ml for both
ointments.
ORGANISMS BACT GENT CHLO NYST WF
μg/ml μg/ml μg/ml μg/ml μg/ml
Pseudomonas aeruginosa 1 160 400 200 ND ND
Pseudomonas aeruginosa 2 160 280 200 ND ND
Pseudomonas aeruginosa 3 100 320 180 ND ND
Pseudomonas aeruginosa 4 100 260 400 ND ND
Pseudomonas aeruginosa 5 140 200 200 ND ND
Streptococcus pyogene 1 200 200 160 ND ND
Streptococcus pyogene2 180 200 200 ND ND
Streptococcus pyogene3 180 200 400 ND ND
Streptococcus pyogene4 180 200 200 ND ND
Streptococcus pyogene5 200 200 200 ND ND
Staphylococcus aureus 1 100 50 250 ND ND
Staphylococcus aureus 2 200 100 400 ND ND
Staphylococcus aureus 3 200 100 400 ND ND
Staphylococcus aureus 4 200 100 200 ND ND
Staphylococcus aureus 5 200 100 200 ND ND
Staph. aureus ATCC29213 100 50 400 ND ND
Candida albicans 1 ND ND ND 160 200
Candida albicans 2 ND ND ND 100 180
Candida albicans 3 ND ND ND 100 240
Candida albicans 4 ND ND ND 140 200
Candida albicans 5 ND ND ND 120 200
Table 2: Minimum inhibitory concentration of  test antimicrobial ointments on selected organisms.
Key: ND= Not Determined due to the nature of organisms concerned.
Bact: Bactroban,  Gent: Gentamicin,  Chlo: Chloramphenicol, Nyst: Nystatin,  WF:Whitefield
ORGANISMS BACT GEN CHLO NYST. WF
μg/ml μg/ml μg/ml μg/ml μg/ml
Pseudomonas aeruginosa 180 400 400 ND ND
Streptococcus pyogene 400 400 400 ND ND
Staph. aureus 200 200 400 ND ND
Staph. aureus  ATCC29213 200 100 200 ND ND
Candida albicans ND ND ND 200 240
tested. Staphylococcus aureus ATCC 29213 was susceptible
to the ointment. All isolates of Pseudomonas aeruginosa
were resistant to chloramphenicol ointment while four
of the five isolates of Streptococcus pyogenes were
susceptible to chloramphenicol. Three Staphylococcus
aureus strains were susceptible while the remaining two
and a typed strain were resistant to chloramphenicol
The minimum inhibitory concentrations of bactroban
against Streptococcus pyogene ranged between 180µg/ml
- 200µg/ml while the MIC values of the same
gentamicin and chloramphenicol were between 160µg/
ml – 400µg/ml against the isolates of Streptococcus
pyogene.
Table 3: Minimum bactericidal concentration of  test antimicrobial agents on selected organisms.
Key:  ND= Not Determined due to the nature of organisms concerned.
Bact: Bactroban  Gent: Gentamicin  Chlo: Chloramphenicol Nyst: Nystatin  WF:Whitefield
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The MIC of bactroban against Staphylococcus aureus  and
a typed strain ranged between 100µg/ml - 200µg/ml
while it varied from 50µg/ml - 100µg/ml against
gentamicin and it ranged between 200µg/ml - 400µg/
ml against chloramphenicol.
The MIC of nystatin against Candida albicans  ranged
between 100µg/ml -160µg/ml  and for whitefield
the MIC ranged between 180µg/ml -240µg/ml
respectively as shown in Table 2.
The minimum bactericidal concentrations of the test
antimicrobial agents were observed to be double the
MIC. The MBC values of bactroban and gentamicin
against Pseudomonas aeruginosa and Streptococcus pyogenes
was between 180µg/ml and 400µg/ml while the MBC
values of the same agent was 200µg/ml each against
both Staphylococcus aureus investigated. The MBC values
of 400µg/ml were recorded for chloramphenicol
against the clinical isolates of Staphylococcus aureus and
while a typed strain of Staphylococcus aureus had MBC
value of 200µg/ml. The MBC of 200µg/ml and
240µg/ml of nystatin and whitefield were obtained
for Candida albicans as shown in Table 3.
The bactericidal activity of bactoban showed varied
population reduction at a different concentration. It
took 3 hours for bactroban to effect total population
reduction to zero at 2MBC against Pseudomonas
aeruginosa as shown in Figure 1 below.
At 2MBC, it took 7 hours for bactroban to effect
total population reduction to zero against Staphylococcus
aureus as shown in Figure 3 below.
Figure 1: Kill kinetic of bactroban on Pseudomonas
aeruginosa.
At 2MBC, it took 6 hours for bactroban to effect
total population reduction to zero against Streptococcus
pyogene as showed in Figure 2.
Fig. 2: Kill kinetic of  bactroban on Streptococcus pyogene.
Fig. 3: Kill kinetic of  bactroban on Staphylococcus aureus.
At 2MBC, it took 4 hours for bactroban to effect
total population reduction to zero against Staphylococcus
aureus 29213 as shown in Figure 4 below.
Fig. 4.: Kill kinetic of  bactroban on Staphylococcus aureus
29213.
At 2MBC, it took 2 hours for nystatin  to effect total
population reduction to zero against Candida albicans
as shown in Figure 5.
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At 2MBC, it took 2 hours for whitefield to effect total
population reduction to zero against Candida albicans
as showed in figure 6 below
the exception of Streptococcus pyogenes 5. Three of the
five isolates of Staphylococcus aureus and the typed strain
of Staphylococcus aureus were susceptible to bactroban.
This could be due its ability to inhibit protein synthesis
by reversibly and specifically binding to isoleuci-
transfer-RNA synthetase16.
Gentamicin, an aminoglycosides, has been used in
serious infections caused by bacteria that are resistant
to other drugs. Gentamicin sulphate at a concentration
of 0.1% has been used topically in creams for infected
burns and skin lesions. It had no activity on Pseudomonas
aeruginosa in this study, but four of  the five isolates of
Streptococcus pyogenes were susceptible to gentamicin with
the exception of Streptococcus pyogenes 4 that is resistant
to gentamicin. Also, three of  the five Staphylococcus aureus
strains were susceptible to gentamicin while
Staphylococcus aureus1 and 2 were resistant to the
gentamicin ointment tested. Staphylococcus aureus ATCC
29213 was susceptible to the ointment, which could
be attributed to overexposure of this antimicrobial
agent to the organism that had facilitated its resistance17.
Chloramphenicol is a broad-spectrum antibiotic
originally isolated from Streptomyces venezuelae but now
manufactured synthetically. It is primarily bacteriostatic
and is indicated in the treatment of superficial ocular
infection involving the conjunctivas caused by
chloramphenicol susceptible organisms. All isolates of
Pseudomonas aeruginosa in this study were resistant to
chloramphenicol ointment while four of the five
isolates of Streptococcus pyogenes were susceptible to
chloramphenicol. Three Staphylococcus aureus were
susceptible while the remaining two Staphylococcus aureus
and a typed strain of Staphylococcus aureus were resistant
to chloramphenicol ointment. This could be attributed
to the inherent nature of the tests organisms, strain
variation and abuse of this drug as a result of unguided
use18.
All the isolates of Candida albicans were susceptible to
nystatin and Whitefield’s but at relatively varied
concentrations which may be due to genetic
composition of these isolates that made them
susceptible and also could be attributed to the efficacy
of these antifungal agents at the concentrations
applied19.
In this study, bactroban and chloramphenicol showed
antibacterial activity that compared favourably with
each other. However, there was a little disparity in the
minimum inhibitory concentration and minimum
bactericidal values obtained for chloramphenicol.
Bactroban and gentamicin ointments were found to
be effective against typed strain of Staphylococcus aureus
while chloramphenicol was less effective on
Staphylococcus aureus20
Fig. 5: Kill kinetic of  nystatin on Candida albicans.
Fig. 6: Kill kinetic of  whitefield on Candida albicans.
DISCUSSION.
In comparing antimicrobial ointments in an in-vitro
experiment, minimum inhibitory concentration,
minimum bactericidal concentration and kinetics of
bactericidal activity of the agents are three important
parameters to indicate antimicrobial activity of an agent.
The three antibacterial ointments (bactroban, gentamicin
and chloramphenicol) and two antifungal ointments
(nystatin and Whitefield) were assessed for antimicrobial
activity and they showed varied activity on selected
clinical isolates15.
Bactroban (mupirocin), a naturally occurring antibiotic
produced by fermentation of Pseudomonas florescens, is
active against a wide range of both Gram negative
and Gram positive organisms. It exerts its bacteriostatic
activity at low concentrations and its bactericidal activity
at high concentrations when applied locally. Bactroban
showed antipseudomonas properties in this study, all
the test isolates of Pseudomonas aeruginosa were
susceptible to bactroban while four out of the five
isolates of Streptococcus pyogenes 5 were resistant with
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Nystatin and Whitefield showed antifungal activity
against Candida albicans but with relatively higher than
minimum bactericidal concentration. In this study,
Whitefield’s appears to be more effective than nystatin.
The kill kinetic timing for bactroban (the only
representative ointment selected in this study) varied
from one test organisms to the other, it took 3 hours
to achieved population reduction to zero at 2 MBC
on Pseudomonas aeruginosa, a Gram negative bacterium
while it took 6hr against Streptococcus pyogenes. This
susceptibility could be attributed to cellular
composition of  the tests isolates. Bactroban took 7
hours that twice the MBC value to reduce the
population of Staphylococcus aureus to zero in this study
while the typed strain of Staphylococcus aureus subjected
to the same test was reduced to zero within the time
limit of 4 hours as showed in figure 3 and 4 above.
Nystatin and Whitefield expressed their killing kinetic
on Candida albicans at 2 hours in this study which could
be traced their relatively closer MBC in this study21.
The results obtained in this study showed varied
antimicrobial activity of the agents used on selected
microbes. Over-exposure and preventive application
of the antimicrobial agents coupled with the possibility
of their addition to other creams or ointments might
be responsible for the low activity of some of the
ointments.  Further research may be carried out on the
antimicrobial ointments tested.
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